RecruitingPhase 1Phase 2NCT05688488

Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords


Sponsor

Eye & ENT Hospital of Fudan University

Enrollment

100 participants

Start Date

May 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To provide a novel therapy idea and method to solve the clinical problem of postoperative adhesion of bilateral vocal cords, patients enrolled in this study will be applied with curcumin on both wound sites of bilateral vocal cords after the surgery on the bilateral vocal cord endoscopically.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria2

  • Patients with bilateral vocal cord diseases who are going to undergo resection of bilateral vocal cord lesions endoscopically.
  • Patients with bilateral vocal cord adhesion who are going to undergo incision of bilateral vocal cord adhesion endoscopically.

Exclusion Criteria6

  • Patients with other laryngeal diseases.
  • Patients with cardiac and pulmonary insufficiency.
  • Patients unable to cooperate with the follow-up on time after surgery.
  • Patients who refuse to sign the informed consent after notification.
  • Patients who have a severe allergic disease or allergic history to a variety of drugs.
  • Other circumstances that are not appropriate to be included in the clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCurcumin

Curcumin was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.

DRUGMitomycin-C

Mitomycin-C was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.


Locations(1)

Eye & ENT Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05688488


Related Trials